These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8453980)

  • 1. Increases in rat striatal extracellular dopamine and vacuous chewing produced by two sigma receptor ligands.
    Patrick SL; Walker JM; Perkel JM; Lockwood M; Patrick RL
    Eur J Pharmacol; 1993 Feb; 231(2):243-9. PubMed ID: 8453980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DTG-induced circling behaviour in rats may involve the interaction between sigma sites and nigro-striatal dopaminergic pathways.
    Bastianetto S; Rouquier L; Perrault G; Sanger DJ
    Neuropharmacology; 1995 Mar; 34(3):281-7. PubMed ID: 7630482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat.
    Gudelsky GA
    J Neural Transm (Vienna); 1999; 106(9-10):849-56. PubMed ID: 10599867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of sigma ligands on the extracellular DOPAC level in rat frontal cortex and striatum.
    Matsuno K; Matsunaga KH; Mita S
    Neurochem Res; 1995 Feb; 20(2):233-8. PubMed ID: 7783846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat.
    Gudelsky GA
    Eur J Pharmacol; 1995 Nov; 286(3):223-8. PubMed ID: 8608783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of rat striatal tyrosine hydroxylase activity following intranigral administration of sigma receptor ligands.
    Weiser SD; Patrick SL; Mascarella SW; Downing-Park J; Bai X; Carroll FI; Walker JM; Patrick RL
    Eur J Pharmacol; 1995 Feb; 275(1):1-7. PubMed ID: 7774655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between modulation of the cerebellorubrospinal system in the in vitro turtle brain and changes in motor behavior in rats: effects of novel sigma ligands.
    Matsumoto RR; Bowen WD; de Costa BR; Houk JC
    Brain Res Bull; 1999 Mar; 48(5):497-508. PubMed ID: 10372510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons.
    Goldstein SR; Matsumoto RR; Thompson TL; Patrick RL; Bowen WD; Walker JM
    Synapse; 1989; 4(3):254-8. PubMed ID: 2558420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Neuropsychopharmacology; 1989 Dec; 2(4):273-9. PubMed ID: 2482026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and neurochemical effects of continuous infusion of cocaine in rats.
    Inada T; Polk K; Purser C; Hume A; Hoskins B; Ho IK; Rockhold RW
    Neuropharmacology; 1992 Jul; 31(7):701-8. PubMed ID: 1407406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iontophoretic effects of sigma ligands on rubral neurons in the rat.
    Matsumoto RR; Walker JM
    Brain Res Bull; 1992; 29(3-4):419-25. PubMed ID: 1356600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of (+)-pentazocine and 1,3-di-o-tolylguanidine (DTG), sigma (sigma) ligands, on micturition in anaesthetized rats.
    Shimizu I; Kawashima K; Ishii D; Oka M
    Br J Pharmacol; 2000 Oct; 131(3):610-6. PubMed ID: 11015314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of local cyanide perfusion on rat striatal extracellular dopamine and its metabolites as studied by in vivo brain microdialysis.
    Kiuchi Y; Inagaki M; Izumi J; Matsumoto M; Yamazaki Y; Oguchi K
    Neurosci Lett; 1992 Dec; 147(2):193-6. PubMed ID: 1491807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia.
    See RE
    Neuropsychopharmacology; 1993 Sep; 9(2):101-9. PubMed ID: 8216693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo.
    Moison D; De Deurwaerdère P; Cagnotto A; Marrazzo A; Prezzavento O; Ronsisvalle G; Mennini T; Spampinato U
    Neuropharmacology; 2003 Dec; 45(7):945-53. PubMed ID: 14573387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent sigma 1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats.
    Goyagi T; Bhardwaj A; Koehler RC; Traystman RJ; Hurn PD; Kirsch JR
    Anesth Analg; 2003 Feb; 96(2):532-8, table of contents. PubMed ID: 12538208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of halothane dose on striatal dopamine: an in vivo microdialysis study.
    Miyano K; Tanifuji Y; Eger EI
    Brain Res; 1993 Mar; 605(2):342-4. PubMed ID: 8481785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats.
    Grimm JW; See RE
    Neuroscience; 2000; 100(3):507-14. PubMed ID: 11098113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands.
    Ault DT; Werling LL
    Brain Res; 1997 Jun; 760(1-2):210-7. PubMed ID: 9237537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microinjection of sigma ligands into cranial nerve nuclei produces vacuous chewing in rats.
    Tran TT; de Costa BR; Matsumoto RR
    Psychopharmacology (Berl); 1998 May; 137(2):191-200. PubMed ID: 9630006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.